TNFRSF9 and head and neck squamous cell carcinoma: Because HNSCC therapy includes surgery, radiotherapy, chemotherapy and immunotherapy [42], we think that detailed evaluation of pretreatment lung MSCT and evaluation of ILA changes should be considered because of earlier described worsening outcomes in patients after treatment.